Delivery Order SPE2DB20D2014-SPE2DB24FB72B
- Not listed
- This federal contract award is a delivery order worth $2,262.32 issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a completion date of February 16, 2024. The contract is a firm fixed price award and does not have a set-aside designation. Amerisourcebergen Drug Corp is an experienced prime contractor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,710.98 firm-fixed-price delivery order covers the supply of Velphoro 500 mg chewable tablets. The contract has a period of performance through March 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the pharmaceutical product VELPHORO 500 MG CHEWABLE TAB 90S. The $5,636 firm fixed price award does not have a set-aside designation and has an ultimate completion date of September 16, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several significant Indefinite Delivery Contracts (IDCs) with federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,807.52, is for the delivery of Velphoro 500 mg chewable tablets. The contract has an ultimate completion date of October 31, 2022 and is a firm-fixed-price delivery order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The contract, valued at $3,547.27, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order with a completion date of June 4, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,822.01, is for the delivery of Velphoro 500 mg chewable tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,581.47 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,679.74, is a delivery order with a firm fixed price. It has a performance period ending on May 16, 2023. The contract was awarded on May 15, 2023, and there is no set-aside designation mentioned....
- This federal contract award, SPE2DB20D3104|SPE2DB22FV3P8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,262.78 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical covering a broad range of pharmaceutical products...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product, with a ceiling value of $1,896.89 and a performance period through May 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB72BDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide VELPHORO 500 MG CHEWABLE TAB 90S. The award has a ceiling value of $3,027.28 and is a firm fixed-price delivery order with an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and this contract is not subject to any set-aside designations. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/25/24 |